Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joseph C Vaglio"'
Publikováno v:
Mayo Clinic Proceedings. 81:537-540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dac328f025cdfb120e55171d3456f8b
https://doi.org/10.4065/81.4.537
https://doi.org/10.4065/81.4.537
Publikováno v:
Nature Clinical Practice Cardiovascular Medicine. 2:659-662
Background A 47-year-old woman with obstructive hypertrophic cardiomyopathy presented with chest pain that had persisted despite treatment with verapamil and α-receptor antagonists. The patient had no other significant cardiac symptoms, no history o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8ca5e655ddbc2a898beb5d738ff06f
https://doi.org/10.1038/ncpcardio0381
https://doi.org/10.1038/ncpcardio0381
Publikováno v:
Journal of Electrocardiology. 44:229-231
We report a patient with numerous abnormal electrocardiograms (ECGs) in both inpatient and outpatient settings. Our patient both simulated and stimulated her arrhythmias with an ECG rhythm generator and intentional caffeine intoxication. To our knowl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56438ada724b5cfb58364b211c3d82c8
https://doi.org/10.1016/j.jelectrocard.2010.08.006
https://doi.org/10.1016/j.jelectrocard.2010.08.006
Autor:
Joseph C Vaglio, Shane B Rowan, Gayle Kucera, Tanya D Stubblefield, Shannon Carter, Dan M Roden, Dawood Darbar
Publikováno v:
Circulation. 118
Background: Randomized studies have now shown that ventricular rate control is an acceptable strategy in patients with atrial fibrillation (AF). Beta-blockers are the first line pharmacologic agent used for ventricular rate control. Recently, a non-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea8a542e4f253101ca6f63ab2e603346
https://doi.org/10.1161/circ.118.suppl_18.s_828-a
https://doi.org/10.1161/circ.118.suppl_18.s_828-a
Publikováno v:
American heart journal. 156(2)
The purpose of this article is to describe the demographic and clinical features of patients with hypertrophic cardiomyopathy (HCM) and latent obstruction, with an emphasis on identifying factors associated with disease progression and survival. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9294d09afc927ad87a99f51cd5c3250
https://pubmed.ncbi.nlm.nih.gov/18657666
https://pubmed.ncbi.nlm.nih.gov/18657666
Autor:
Joseph C. Vaglio, Adam M. Reyburn
Publikováno v:
Mayo Clinic Proceedings. 81:824
A 63-year-old woman with a history of hypertension and paroxysmal supraventricular tachycardia presented with substernal chest pain that extended to her back and was associated with profound weakness and shortness of breath. Physical examination reve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed07ccf6c86d78ba5e66763e523f152d
https://doi.org/10.4065/81.6.824
https://doi.org/10.4065/81.6.824